China SXT Pharmaceuticals, Inc.
$0.07 +$0.01 (+9.40%) 1D Pre-marketKey Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 24
Offering paper hit the record (Form 424B5).
424B5 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer)
RECEIPT: SEC FORM 424B5, TIMESTAMPED -
Jul 24
From its Feb 2 high, the share price fell 99%.
Peak close $6.47 on Feb 2; trough close $0.06 on Jul 24. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -99% -
Jul 24
The stock moved -80.8% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Jul 24 -
Jul 23
The stock moved -83.5% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Jul 23 -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE
The story updates itself as events post · The wolf reports; you decide
Snapshot
About China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM…
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.